Taiyang Ye
Overview
Explore the profile of Taiyang Ye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang C, Ye T, Wang W, Song K, Zhu J, Dai L, et al.
Exp Hematol Oncol
. 2022 Nov;
11(1):102.
PMID: 36384540
Unlike many solid tumors, epithelial ovarian cancer (EOC) has a clear metastatic predilection to the adipocyte-rich niche, especially the omentum. However, the underlying mechanism driving this process remains incomplete. Here...
2.
Dai L, Wang C, Wang W, Song K, Ye T, Zhu J, et al.
Open Med (Wars)
. 2022 Feb;
17(1):229-238.
PMID: 35178477
Epithelial ovarian cancer (EOC) is the leading cause of deaths due to cancer in women. Adipocytes have been suggested to play a key role in the stimulation of EOC growth....
3.
Chen C, Li C, Liu W, Guo F, Kou X, Sun S, et al.
J Biol Chem
. 2020 Jan;
295(8):2248-2258.
PMID: 31937587
The regulation mechanisms involved in matrix metalloproteinase () expression and the motility of human endometrial and decidual stromal cells (ESCs and DSCs, respectively) during decidualization remain unclear. DSCs show significant...
4.
Chen C, Li Y, Hou S, Bourbon P, Qin L, Zhao K, et al.
Microvasc Res
. 2019 Oct;
128:103934.
PMID: 31654655
Pathological angiogenesis is a hallmark of many diseases. Previously, we reported that orphan nuclear receptor TR3/Nur77 was a critical mediator of angiogenesis to regulate tumor growth, sepsis and skin wound...
5.
Peng J, Zhao S, Li Y, Niu G, Chen C, Ye T, et al.
Microvasc Res
. 2019 Apr;
124:67-75.
PMID: 30930165
Pathological angiogenesis is a hallmark of many diseases. Previously, we reported that orphan nuclear receptor TR3/Nur77 was a critical mediator of angiogenesis to regulate tumor growth and skin wound healing...
6.
Ye T, Peng J, Liu X, Hou S, Niu G, Li Y, et al.
Microvasc Res
. 2018 Nov;
122:22-33.
PMID: 30391133
Pathological angiogenesis is a hallmark of many diseases. Previously, we reported that orphan nuclear receptor TR3/Nur77 (human homolog, Nur77, mouse homolog) is a critical mediator of angiogenesis to regulate tumor...
7.
Wu J, Ye T, Lv J, He Z, Zhu J
J Minim Invasive Gynecol
. 2018 Oct;
26(3):417-426.e6.
PMID: 30359783
It is widely accepted that nerve-sparing radical hysterectomy is associated with less postoperative morbidity compared with radical hysterectomy, whereas clinical safety is similar in the 2 procedures. However, there is...
8.
Jia J, Ye T, Cui P, Hua Q, Zeng H, Zhao D
Microvasc Res
. 2016 Feb;
105:103-8.
PMID: 26860974
VEGF, upon binding to its endothelial cell specific receptors VEGF-R1 and VEGF-R2, can induce endothelial cell migration, proliferation and angiogenesis. However, the molecular mechanism of these effects still remains unclear....
9.
Zhou L, Cui P, Zhao S, Ye T, Li Y, Peng J, et al.
Tumour Biol
. 2015 Oct;
37(3):3307-20.
PMID: 26440050
TR3 has been reported to be an excellent target for angiogenesis therapies. We reported three TR3 transcript variant messenger RNAs (mRNAs) are expressed in human umbilical vein endothelial cell (HUVEC)...
10.
Li Y, Bourbon P, Grant M, Peng J, Ye T, Zhao D, et al.
Oncotarget
. 2015 Jul;
6(27):24261-76.
PMID: 26155943
Pathological angiogenesis is a hallmark of many diseases. We demonstrated that TR3/Nur77 is an excellent target for pro-angiogenesis and anti-angiogenesis therapies. Here, we report that TR3 transcriptionally regulates endothelial cell...